首页> 美国卫生研究院文献>Infection and Immunity >Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.
【2h】

Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

机译:在膜攻击复合物形成的水平上发生补体抗性和补体敏感性莫拉氏菌(布拉汉菌)卡他氏菌菌株之间补体激活的差异。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mechanism of resistance to human complement-mediated killing in Moraxella catarrhalis was studied by comparing different complement-sensitive and complement-resistant M. catarrhalis strains in a functional bystander hemolysis assay and an enzyme-linked immunosorbent assay (ELISA) for soluble terminal complement complexes. Complement-resistant stains appeared to activate complement to the same extent as, or even slightly better than, complement-sensitive strains. This indicates that complement-resistant strains do not inhibit classical or alternative pathway activation but interfere with complement at the level of membrane attack complex formation. A clear difference in dose-response curves for resistant and sensitive strains was observed both in the bystander hemolysis assay and in the ELISA. Complement-resistant strains showed optimum curves, whereas complement-sensitive strains gave almost linear curves. We conclude that resistant strains bind and/or inactivate one of the terminal complement components or intermediates involved in membrane attack complex formation. Trypsin, known to abolish complement resistance, changed the optimum dose-response curve of a resistant strain to a linear one, which strongly suggests that complement resistance is mediated by an M. catarrhalis-associated protein. This protein acts directly or through the binding of a terminal complement inhibitor present in serum.
机译:通过在功能性旁观者溶血测定和酶联免疫吸附测定(ELISA)中比较可溶性补体末端补体复合物对补体敏感和补体抗性的卡他莫拉氏菌菌株的影响,研究了对人补体介导的粘膜炎莫拉氏菌杀伤机制的研究。补体抗性染色剂似乎以与补体敏感性菌株相同的程度甚至甚至更好地激活补体。这表明补体抗性菌株不抑制经典或替代途径的活化,但在膜攻击复合物形成的水平上干扰补体。在旁观者溶血试验和ELISA中均观察到耐药菌株和敏感菌株的剂量反应曲线存在明显差异。耐补体菌株显示最佳曲线,而对补体敏感菌株显示几乎线性的曲线。我们得出结论,抗性菌株结合和/或灭活参与膜攻击复合物形成的末端补体成分或中间体之一。已知消除补体抗性的胰蛋白酶将抗性菌株的最佳剂量反应曲线更改为线性菌株,这强烈表明补体抗性由卡他莫拉氏菌相关蛋白介导。该蛋白直接作用或通过结合血清中存在的末端补体抑制剂起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号